What is Teva Pharmaceutical Industries Limited's current stock price?

Teva Pharmaceutical Industries Limited (TEVA) currently trades at USD 34.03. Track real-time price changes and historical performance on AllInvestView.

What sector is Teva Pharmaceutical Industries Limited in?

Teva Pharmaceutical Industries Limited operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Teva Pharmaceutical Industries Limited TEVA Open Teva Pharmaceutical Industries Limited in new tab

34.03 USD

P/E

25.59

EPS

1.34

P/B

4.85

ROE

21.60

Beta

0.86

Target Price

40.27 USD

Teva Pharmaceutical Industries Limited

🧾 Earnings Recap – Q3 2025

Teva Pharmaceutical Industries reported robust growth in Q3 2025, achieving its 11th consecutive quarter of revenue increase, with total revenue up 3% year-over-year and adjusted EBITDA rising 6%.

Revenue reached $4.5 billion, driven by a 33% increase in innovative product sales, totaling over $800 million.
AUSTEDO's revenue grew 38% year-over-year, surpassing $600 million for the first time, and reaffirmed a 2027 revenue target of $2.5 billion.
UZEDY experienced a 24% revenue increase with a 119% rise in TRx, confirming long-term peak sales ambitions of $1.5 billion to $2 billion.
Free cash flow exceeded $0.5 billion, and net debt to EBITDA improved to below 3x, marking a significant financial milestone for the firm.

View full recap page

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Teva Pharmaceutical Industries Limited (TEVA)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Teva Pharmaceutical Industries Limited Analysis (TEVA)

Israel Health Care Official Website Stock

Is Teva Pharmaceutical Industries Limited a good investment? Teva Pharmaceutical Industries Limited (TEVA) is currently trading at 34.03 USD. Market analysts have a consensus price target of 40.27 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 25.59. This valuation is generally in line with the broader market.

Earnings Schedule: Teva Pharmaceutical Industries Limited is expected to release its next earnings report on July 29, 2026. The market consensus estimate for Forward EPS is 3.10.

Investor FAQ

Does Teva Pharmaceutical Industries Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of 1.34.

Company Profile

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Exchange Ticker

NYQ (United States) TEVA

Historical Dividends

Year	Total Dividends
2017	0.85 USD
Dec. 12, 2017	0.0850
Sept. 14, 2017	0.0850
June 22, 2017	0.3400
March 20, 2017	0.3400
2016	1.36 USD
Dec. 20, 2016	0.3400
Sept. 8, 2016	0.3400
June 7, 2016	0.3400
March 14, 2016	0.3400
2015	1.36 USD
Dec. 3, 2015	0.3400
Sept. 3, 2015	0.3400
June 4, 2015	0.3400
March 3, 2015	0.3400
2014	1.37 USD
Dec. 2, 2014	0.3210
Sept. 4, 2014	0.3530
June 2, 2014	0.3470
March 10, 2014	0.3450
2013	1.28 USD
Dec. 3, 2013	0.3260
Sept. 3, 2013	0.3220
June 3, 2013	0.3200
March 7, 2013	0.3100
2012	1.03 USD
Dec. 3, 2012	0.2570
Sept. 4, 2012	0.2490
June 4, 2012	0.2610
Feb. 23, 2012	0.2670
2011	0.90 USD
Dec. 7, 2011	0.2190
Aug. 25, 2011	0.2350
June 7, 2011	0.2320
March 7, 2011	0.2150
2010	0.75 USD
Dec. 6, 2010	0.1930
Aug. 26, 2010	0.1810
May 10, 2010	0.1880
Feb. 19, 2010	0.1860
2009	0.61 USD
Nov. 6, 2009	0.1580
Aug. 3, 2009	0.1540
May 8, 2009	0.1450
Feb. 23, 2009	0.1480
2008	0.50 USD
Nov. 7, 2008	0.1170
Aug. 1, 2008	0.1300
May 13, 2008	0.1310
Feb. 15, 2008	0.1250
2007	0.39 USD
Nov. 2, 2007	0.1010
Aug. 10, 2007	0.0920
May 10, 2007	0.0980
Feb. 16, 2007	0.0940
2006	0.31 USD
Nov. 10, 2006	0.0790
Aug. 11, 2006	0.0780
May 12, 2006	0.0770
March 6, 2006	0.0720
2005	0.27 USD
Nov. 10, 2005	0.0640
Aug. 11, 2005	0.0670
May 5, 2005	0.0690
Feb. 17, 2005	0.0690
2004	0.20 USD
Nov. 9, 2004	0.0510
Aug. 9, 2004	0.0500
May 10, 2004	0.0490
Feb. 20, 2004	0.0505
2003	0.16 USD
Nov. 13, 2003	0.0365
Aug. 8, 2003	0.0375
May 8, 2003	0.0370
Feb. 24, 2003	0.0340
Jan. 7, 2003	0.0175
2002	0.09 USD
Nov. 7, 2002	0.0225
Aug. 19, 2002	0.0228
May 20, 2002	0.0220
Feb. 15, 2002	0.0233
2001	0.06 USD
Nov. 16, 2001	0.0160
Aug. 20, 2001	0.0160
May 17, 2001	0.0163
March 8, 2001	0.0165
2000	0.04 USD
Nov. 16, 2000	0.0138
Aug. 24, 2000	0.0140
May 19, 2000	0.0135
1999	0.03 USD
Nov. 4, 1999	0.0066
Aug. 18, 1999	0.0069
May 21, 1999	0.0069
March 8, 1999	0.0073
1998	0.04 USD
Dec. 11, 1998	0.0081
Nov. 16, 1998	0.0081
Aug. 21, 1998	0.0081
May 21, 1998	0.0081
March 12, 1998	0.0085
1997	0.03 USD
Nov. 20, 1997	0.0085
Aug. 25, 1997	0.0085
May 23, 1997	0.0075
March 7, 1997	0.0065
1996	0.03 USD
Nov. 20, 1996	0.0063
Aug. 26, 1996	0.0063
May 23, 1996	0.0063
March 7, 1996	0.0063
1995	0.03 USD
Nov. 20, 1995	0.0063
Aug. 14, 1995	0.0063
May 17, 1995	0.0081
March 7, 1995	0.0065
1994	0.02 USD
Nov. 15, 1994	0.0060
Aug. 9, 1994	0.0063
March 8, 1994	0.0053
1993	0.02 USD
Nov. 17, 1993	0.0046
Aug. 17, 1993	0.0046
May 18, 1993	0.0044
April 7, 1993	0.0025
1992	0.01 USD
Nov. 17, 1992	0.0025
Aug. 18, 1992	0.0031
May 19, 1992	0.0026
March 3, 1992	0.0022
1991	0.01 USD
Nov. 20, 1991	0.0022
Aug. 21, 1991	0.0022
May 20, 1991	0.0025
March 5, 1991	0.0025
1990	0.01 USD
Nov. 20, 1990	0.0023
Aug. 17, 1990	0.0023
May 21, 1990	0.0022
March 8, 1990	0.0024
1989	0.01 USD
Nov. 20, 1989	0.0019
Aug. 16, 1989	0.0019
May 22, 1989	0.0019
March 9, 1989	0.0023
1988	0.01 USD
Dec. 6, 1988	0.0019
Sept. 8, 1988	0.0023
June 10, 1988	0.0018
April 12, 1988	0.0019
Feb. 8, 1988	0.0019
1987	0.01 USD
Oct. 23, 1987	0.0019
July 9, 1987	0.0024
June 22, 1987	0.0019
Feb. 23, 1987	0.0019

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Split Date	Split Ratio to 1
Feb. 23, 2000	2.000000
Dec. 6, 2002	2.000000
July 1, 2004	2.000000
April 14, 1993	2.000000
Aug. 16, 1982	1.400000

Trades

Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Community Discussion

Twitter YouTube Reddit Feature Requests Support Pricing Help

Support email: support@allinvestview.com

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.

Teva Pharmaceutical Industries Limited TEVA Open Teva Pharmaceutical Industries Limited in new tab

Teva Pharmaceutical Industries Limited

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Teva Pharmaceutical Industries Limited Analysis (TEVA)

Investor FAQ

Company Profile

Historical Dividends

Dividends

Historical Split Corporate Actions

Explore Premium Features

Under Construction

Community Discussion

Teva Pharmaceutical Industries Limited TEVA Open Teva Pharmaceutical Industries Limited in new tab

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Teva Pharmaceutical Industries Limited Analysis (TEVA)

Investor FAQ

Company Profile

Historical Dividends

Dividends

Historical Split Corporate Actions

Explore Premium Features

Under Construction

Community Discussion

Notifications